Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA
Chetan Huded(Health Innovations (United States)), Ira Dauber, Marvin W. Kronenberg, Richard Goldweit, Subhash Banerjee(Baylor University Medical Center), John A. Spertus(Saint Luke's Health System), Mikhail Torosoff, Michael D. Shapiro(Wake Forest University), Santiago García(Minneapolis VA Health Care System), Todd Q. Miller, Edward O. McFalls, Daniel B. Mark(Duke University), James H. O’Keefe(Saint Luke's Hospital), Victor J. Navarro(Thomas Jefferson University Hospital), Michel G. Khouri(University of North Carolina at Chapel Hill), Suzanne V. Arnold(Saint Luke's Health System), Steven Weitz, Robert Donnino, Jason Linefsky, John F. Heitner(New York University), Brooks Mirrer, Harmony R. Reynolds(Anna Needs Neuroblastoma Answers), Gregg W. Stone(Cardiovascular Institute of the South), David J. Maron(Stanford Medicine), Jonathan Newman(New York University), Radmila Lyubarova, Sripal Bangalore(New York University), Muhamed Sarić(NYU Langone Health), Gennie Yee, Harvey D. White(University of Auckland), Kreton Mavromatis, William E. Boden(VA New England Healthcare System), Khaled Abdul‐Nour, Rizwan A. Siddiqui, Philip G. Jones(University of Missouri–Kansas City), Krzysztof Drzymalski, Judith S. Hochman(New York University), David E. Winchester, Ronny Cohen, Jonathan Goldberg, Sean M. O’Brien(Duke University), David O. Williams(Brigham and Women's Hospital), Areef Ishani(University of Minnesota), Steven Fein, Stefan Bertog(Laboratoire Traitement du Signal et de l'Image), James J. Jang(Kaiser Permanente), Sulagna Mookherjee, Peter Stone(The University of Texas at Austin), Ronnell A. Hansen, Christopher McFarren
Cited by 7
Related Papers
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k